CID 510036

5-(1-ethyl-3-phenethyl-2h-benzimidazol-2-yl)-1,3-diphenyl-imidazolidine-2,4-dione

Structural Information

Molecular Formula
C32H30N4O2
SMILES
CCN1C(N(C2=CC=CC=C21)CCC3=CC=CC=C3)C4C(=O)N(C(=O)N4C5=CC=CC=C5)C6=CC=CC=C6
InChI
InChI=1S/C32H30N4O2/c1-2-33-27-20-12-13-21-28(27)34(23-22-24-14-6-3-7-15-24)30(33)29-31(37)36(26-18-10-5-11-19-26)32(38)35(29)25-16-8-4-9-17-25/h3-21,29-30H,2,22-23H2,1H3
InChIKey
TVUQHYXWLXKGPX-UHFFFAOYSA-N
Compound name
5-[1-ethyl-3-(2-phenylethyl)-2H-benzimidazol-2-yl]-1,3-diphenylimidazolidine-2,4-dione
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

502.23688 Da
Monoisotopic Mass

6.7
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 503.24416 227.2
[M+Na]+ 525.22610 233.5
[M-H]- 501.22960 238.5
[M+NH4]+ 520.27070 231.7
[M+K]+ 541.20004 223.9
[M+H-H2O]+ 485.23414 212.9
[M+HCOO]- 547.23508 240.8
[M+CH3COO]- 561.25073 233.3
[M+Na-2H]- 523.21155 220.3
[M]+ 502.23633 226.0
[M]- 502.23743 226.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.